Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow-to-Debt Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of ILA313.17 Million could theoretically repay 0% of its total liabilities (ILA32.11 Billion) in one year. Explore Teva Pharmaceutical Industries Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Teva Pharmaceutical Industries Ltd Cash Flow-to-Debt Ratio (1991–2025)
Historical debt coverage capacity for Teva Pharmaceutical Industries Ltd across 35 annual periods. Also explore Teva Pharmaceutical Industries Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year debt coverage analysis for Teva Pharmaceutical Industries Ltd. For market capitalisation and broader financial context, see TEVA market cap.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ILA3.10 Billion | ILA32.84 Billion | ▲ +154.3% |
| 2024 | 0.04x | ILA1.25 Billion | ILA33.61 Billion | ▼ -4.1% |
| 2023 | 0.04x | ILA1.37 Billion | ILA35.35 Billion | ▼ -14.1% |
| 2022 | 0.05x | ILA1.59 Billion | ILA35.31 Billion | ▲ +105.5% |
| 2021 | 0.02x | ILA798.00 Million | ILA36.42 Billion | ▼ -28.7% |
| 2020 | 0.03x | ILA1.22 Billion | ILA39.58 Billion | ▲ +142.2% |
| 2019 | 0.01x | ILA538.00 Million | ILA42.41 Billion | ▼ -76.7% |
| 2018 | 0.05x | ILA2.45 Billion | ILA44.89 Billion | ▼ -19.4% |
| 2017 | 0.07x | ILA3.51 Billion | ILA51.87 Billion | ▼ -25.1% |
| 2016 | 0.09x | ILA5.22 Billion | ILA57.90 Billion | ▼ -60.4% |
| 2015 | 0.23x | ILA5.54 Billion | ILA24.33 Billion | ▲ +2.5% |
| 2014 | 0.22x | ILA5.13 Billion | ILA23.07 Billion | ▲ +70.8% |
| 2013 | 0.13x | ILA3.24 Billion | ILA24.87 Billion | ▼ -21.0% |
| 2012 | 0.16x | ILA4.57 Billion | ILA27.74 Billion | ▲ +10.8% |
| 2011 | 0.15x | ILA4.13 Billion | ILA27.80 Billion | ▼ -38.7% |
| 2010 | 0.24x | ILA4.14 Billion | ILA17.05 Billion | ▲ +4.6% |
| 2009 | 0.23x | ILA3.37 Billion | ILA14.55 Billion | ▲ +18.7% |
| 2008 | 0.20x | ILA3.23 Billion | ILA16.54 Billion | ▲ +4.0% |
| 2007 | 0.19x | ILA1.81 Billion | ILA9.65 Billion | ▼ -15.2% |
| 2006 | 0.22x | ILA2.06 Billion | ILA9.29 Billion | ▼ -29.9% |
| 2005 | 0.32x | ILA1.37 Billion | ILA4.34 Billion | ▲ +7.1% |
| 2004 | 0.30x | ILA1.25 Billion | ILA4.23 Billion | ▲ +23.4% |
| 2003 | 0.24x | ILA626.60 Million | ILA2.62 Billion | ▲ +88.8% |
| 2002 | 0.13x | ILA353.70 Million | ILA2.79 Billion | ▼ -3.7% |
| 2001 | 0.13x | ILA273.15 Million | ILA2.08 Billion | ▲ +35.2% |
| 2000 | 0.10x | ILA165.63 Million | ILA1.70 Billion | ▼ -38.5% |
| 1999 | 0.16x | ILA153.61 Million | ILA971.72 Million | ▲ +74.8% |
| 1998 | 0.09x | ILA70.20 Million | ILA776.40 Million | ▼ -73.1% |
| 1997 | 0.34x | ILA193.60 Million | ILA575.60 Million | ▲ +3593.0% |
| 1996 | -0.01x | ILA-6.80 Million | ILA706.20 Million | ▼ -104.2% |
| 1995 | 0.23x | ILA105.40 Million | ILA463.70 Million | ▲ +98.5% |
| 1994 | 0.11x | ILA38.20 Million | ILA333.60 Million | ▼ -10.4% |
| 1993 | 0.13x | ILA37.70 Million | ILA295.00 Million | ▲ +0.6% |
| 1992 | 0.13x | ILA28.20 Million | ILA221.90 Million | ▲ +170.5% |
| 1991 | 0.05x | ILA9.10 Million | ILA193.70 Million | — |